This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Jeremy Edmunds: Pioneering Immunological and Oncological Treatments
Introduction
Jeremy Edmunds is an accomplished inventor based in Acton, MA, whose work has made significant strides in the field of medicine. With a focus on pharmaceutical innovations, Jeremy has secured a patent for a groundbreaking compound that promises to enhance treatment options for various diseases, particularly those relating to immunological and oncological conditions.
Latest Patents
Jeremy holds a patent for "Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof." This invention encompasses a compound formula that includes pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. The compounds described in the patent are valuable for their potential to address critical healthcare challenges, enhancing treatment modalities for patients suffering from immunological disorders and cancer.
Career Highlights
Jeremy works for AbbVie Inc., a leading biopharmaceutical company known for its innovative approaches to patient care. His dedication to advancing medical science through invention is evident in his research and the successful development of his patented compounds. Collaborating with a talented team and leveraging his scientific expertise, Jeremy has made notable contributions to the pharmaceutical landscape.
Collaborations
Throughout his career, Jeremy has had the opportunity to collaborate with esteemed colleagues such as Dawn M. George and Maria A. Argiriadi. Together, they have worked on various projects that aim to propel advancements in medical treatments, demonstrating the power of teamwork in driving innovation forward.
Conclusion
In summary, Jeremy Edmunds stands out as a notable inventor in the fields of immunology and oncology. His patent signifies a promising step towards novel treatments that can improve patient outcomes. As he continues to work with AbbVie Inc. and collaborate with other experts, the future looks bright for further innovations that could change the landscape of disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile